Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Yuhan Pharmaceuticals to use Cyclica’s AI-driven drug discovery platform Yuhan Pharmaceuticals has entered into a collaboration with Canadian biotechnology company Cyclica to use the latter’s artificial intelligence… bypharmanewsdailyNovember 8, 2019